MEDFORD, Mass., May 19, 2025--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, ...
MEDFORD, Mass.--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today ...
Recombinant adeno-associated virus (rAAV) is currently used as vector in about 250 clinical trials for gene therapy (Bulcha et al., 2021). Nonetheless, there are still several challenges concerning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback